ask="N/A"
ask_size="N/A"
average_daily_volume="29071"
bid="3.12"
bid_size="100"
book_value="3.34"
change="-0.18"
change_from_200_day_moving_average="3.18"
change_from_50_day_moving_average="2.09"
change_from_52_week_high="-1.18"
change_From_52_week_low="6.30"
change_in_percent="-1.80%"
close="9.82"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.26"
ebitda="-50.28M"
eps_estimate_current_year="-2.61"
eps_estimate_next_quarter="-0.63"
eps_estimate_next_year="-2.86"
ex_dividend_date="N/A"
float_shares="N/A"
high="10.05"
high_52_weeks="11.00"
last_trade_date="2/15/2017"
last_trade_price="9.82"
last_trade_size="100"
last_trade_time="3:59pm"
low="9.70"
low_52_weeks="3.52"
market_capitalization="208.97M"
moving_average_200_day="6.64"
moving_average_50_day="7.73"
name="Nabriva Therapeutics AG"
notes="N/A"
one_year_target_price="16.22"
open="9.80"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+47.95%"
percent_change_from_50_day_moving_average="+27.03%"
percent_change_from_52_week_high="-10.73%"
percent_change_from_52_week_low="+178.98%"
previous_close="10.00"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.99"
price_per_sales="40.92"
revenue="5.20M"
shares_outstanding="21280000"
short_ratio="3.79"
stock_exchange="NMS"
symbol="NBRV"
volume="20874"
weeks_range_52="3.52 - 11.00"
